Get Ready for Novel H1N1 InfluenzaWhat’s the Role of Rapid Tests?By Genna Rollins
Rapid influenza diagnostic tests will have a role in detecting novel H1N1 virus this fall, but laboratorians will need to interpret results within the context of local epidemiology.
Big Study on Small PatientsNational Children’s Study Could Provide Key to Standardized Pediatric Reference IntervalsBy Deborah Levenson
Reference intervals for infants and children are notoriously difficult to define, oftentimes forcing hospital labs to develop their own intervals with little data. If a proposal from AACC’s Pediatric Reference Range Committee moves forward, the National Children’s Study may be the key to developing standardized intervals for several common analytes.
Cardiac IschemiaWhere No Biomarker Has Gone BeforeBy Fred S. Apple, PhD
Despite being one of the most common genetic diseases, α1-antitrypsin deficiency remains largely undiagnosed. Genetic testing can help identify the disease and prevent disease progression, but improvements in testing methodologies and algorithms are needed to increase detection of this disease.
Cost of Obesity Tops $147 Billion Annually
Higher Standards on the Way for Glucose Meters?FDA Seeking ISO Revision to Improve Performance RequirementsBy Bill Malone
Laboratorians have warned that glucose meters are too error-prone. Now FDA agrees it’s time to revisit the standards, but stakeholders worry about a possible increase in meter costs and a resultant decrease in use by diabetics.
News from the FDA
Download the entire issue
Fetal Lung Maturity Testing Traceability and Standardization
Traceability and Standardization